FARMACIA Y SALUD
Doktorego eskola
University of Milano-Bicocca
Milán, ItaliaUniversity of Milano-Bicocca-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
United European Gastroenterology Journal